
    
      Treatment allocation depended on the randomization in the previous study i.e. only the
      subjects from the control group of HPV-039 study received HPV vaccination in the current
      study. Subjects who previously received the Human Papillomavirus (Types 16, 18) Vaccine,
      Adsorbed in HPV-039 study did not receive vaccination in this study.
    
  